Health and Medical

AavantiBio’s core offering is a proprietary gene therapy platform utilizing adeno-associated viruses (AAVs) to deliver therapeutic genes to target cells. This platform is currently focused on developing treatments for Friedreich’s Ataxia and other rare genetic diseases.

Gene Therapy Platform

Science and Engineering

Biotechnology

AavantiBio, Inc.

Massachusetts

Biopharma

Life Science

AavantiBio provides specialized research services related to gene therapy development, including vector design, preclinical studies, and therapeutic development support.

Gene Therapy Research Services

Other products/services from AavantiBio, Inc.

Gene Therapy Platform

N/A